1. Imaging of Neurite Network with an Anti-L1CAM Aptamer Generated by Neurite-SELEX
    Linlin Wang et al, 2018, Journal of the American Chemical Society CrossRef
  2. Mesenchymal Epithelial Transition Factor Signaling in Pediatric Nervous System Tumors: Implications for Malignancy and Cancer Stem Cell Enrichment
    Amanda Rose Khater et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  3. A Novel Mechanism of 17-AAG Therapeutic Efficacy on HSP90 Inhibition in MYCN-Amplified Neuroblastoma Cells
    Reine Hanna et al, 2021, Frontiers in Oncology CrossRef
  4. Tumorigenic proteins upregulated in the MYCN-amplified IMR-32 human neuroblastoma cells promote proliferation and migration
    Hayat Zaatiti et al, 2018, International Journal of Oncology CrossRef
  5. Downregulation of lncRNA XIST Represses Tumor Growth and Boosts Radiosensitivity of Neuroblastoma via Modulation of the miR-375/L1CAM Axis
    Haiyan Yang et al, 2020, Neurochemical Research CrossRef
  6. A Novel Therapeutic Mechanism of Imipridones ONC201/ONC206 in MYCN-Amplified Neuroblastoma Cells via Differential Expression of Tumorigenic Proteins
    Sarra El-Soussi et al, 2021, Frontiers in Pediatrics CrossRef
  7. Silencing of the PHLDA1 leads to global proteome changes and differentiation pathways of human neuroblastoma cells
    Beata Bugara et al, 2024, Frontiers in Pharmacology CrossRef
  8. Cancer Stem Cells in Neuroblastoma: Expanding the Therapeutic Frontier
    Hisham F. Bahmad et al, 2019, Frontiers in Molecular Neuroscience CrossRef
  9. L1 Cell Adhesion Molecule in Cancer, a Systematic Review on Domain-Specific Functions
    null Maten et al, 2019, International Journal of Molecular Sciences CrossRef
  10. Role of L1CAM in retinoblastoma tumorigenesis: identification of novel therapeutic targets
    Oliver Dräger et al, 2022, Molecular Oncology CrossRef
  11. Molecular and functional analysis of anchorage independent, treatment-evasive neuroblastoma tumorspheres with enhanced malignant properties: A possible explanation for radio-therapy resistance
    Tamara J. Abou-Antoun et al, 2018, PLOS ONE CrossRef
  12. Stem Cell Therapy for High-Risk Neuroblastoma: Stem Cell Transplantation and Targeting Cancer Stem Cells
    Sreenidhi Mohanvelu et al, 2024, Reference Module in Biomedical Sciences CrossRef
  13. An ankyrin-binding motif regulates nuclear levels of L1-type neuroglian and expression of the oncogene Myc in Drosophila neurons
    Priyanka P. Kakad et al, 2018, Journal of Biological Chemistry CrossRef
  14. Cancer stem cell signaling in neuroblastoma progression—in touch with reality
    Poorvi Subramanian et al, 2024, Cancer Stem Cells and Signaling Pathways CrossRef
  15. Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting
    Antonietta Rosella Farina et al, 2021, World Journal of Stem Cells CrossRef
  16. Biologicals as theranostic vehicles in paediatric oncology
    Veerle J.A. Niessen et al, 2022, Nuclear Medicine and Biology CrossRef
  17. Interactions of Butyrylcholinesterase with Neuroblastoma-associated Oncoproteins
    Janina Baranowska-Kortylewicz et al, 2023, Current Enzyme Inhibition CrossRef
  18. The Extracellular Matrix and Neuroblastoma Cell Communication—A Complex Interplay and Its Therapeutic Implications
    Irena Horwacik, 2022, Cells CrossRef
  19. Neuroblastoma Origin and Therapeutic Targets for Immunotherapy
    Irina V. Kholodenko et al, 2018, Journal of Immunology Research CrossRef